Jessup, MD, United States of America

Suzanne Sebald

This inventor holds 6 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 2002-2009.


% Patents Active = 83.3

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2002-2009

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Suzanne Sebald

Introduction

Suzanne Sebald is a prominent inventor based in Jessup, MD (US). She has made significant contributions to the field of biotechnology, holding a total of six patents. Her work focuses on growth differentiation factors, which play crucial roles in various biological processes.

Latest Patents

Among her latest patents is the Growth Differentiation Factor-16 (GDF-16). This patent discloses the polynucleotide sequence and amino acid sequence of GDF-16, along with diagnostic and therapeutic methods for utilizing the GDF-16 polypeptide and polynucleotide sequences. Another notable patent is for Growth Differentiation Factor, Lefty-2. This patent also includes its polynucleotide sequence and amino acid sequence, as well as diagnostic and therapeutic methods for using the Lefty-2 polypeptide and polynucleotide sequences.

Career Highlights

Suzanne Sebald is affiliated with The Johns Hopkins University, where she continues her research and innovation in the field. Her work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

Some of her notable coworkers include Se-Jin Lee and Thanh Huynh, who have collaborated with her on various projects.

Conclusion

Suzanne Sebald's contributions to biotechnology through her patents and research at The Johns Hopkins University highlight her role as an influential inventor in her field. Her work continues to pave the way for advancements in diagnostic and therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…